Top 6 Market Research companies in Durham, North Carolina, United States
From industry giants to innovative startups, discover the top-notch firms redefining boundaries.
SJR is primarily engaged in strategic research, so we believe focus groups are the best tool for developing and testing strategic hypotheses. SJR will help you define, refine, and execute a strategic plan, whether you are facing a marketing challenge, a political decision, or a business crisis.
EMH Opinion Sampling is market research data collection service. It take a unique approach to pre-testing questionnaires, proactively managing samples in the field, using technology to improve accuracy, and reporting results. It has completed 3,300 projects and 1.5 million telephone interviews for 15 primary clients.
Jd Franz Research is a Marketing Research Company that is a full-service public opinion firm. It is a DBE, SBE, and WBE certified firm that provides the caliber of the general public, consumer, and business intelligence within a specific time and in a cost-efficient manner. They do both quantitative and qualitative studies for the customer's satisfaction.
Lucien Partners is a consulting firm that helps clients engage with the community by providing advice and guidance. Legislative and regulatory advocacy, thought leadership, strategic planning and research, strategic messaging, coalition building, stakeholder engagement, and external relations are all areas in which they specialize. They give clients recommendations that are adapted to the local time, place, and topic matter to achieve the desired impact with target audiences.
Yuras | Aicale | Forsyth | Crowle Leased Investment Team provides an integrated investment services platform, which incorporates comprehensive real estate investments, capital markets expertise, and integrated market research. They address inquiries through online applications, emails, and phone calls.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.